Amigraf 1.0 Capsule
Product Info
Prescription required | Yes |
Marketer | Biokindle Lifesciences Pvt Ltd |
Active Ingredient | Tacrolimus (1mg) |
Storage | Store below 30°C |
Chemical Class | Macrolide Lactams |
Habit Forming | No |
Therapeutic Class | ANTI NEOPLASTICS |
Action Class | Immunosuppressant- Calcineurin inhibitors |
User Rating | 4.6 |
User Reviews | 644 |
FAQ
Amigraf 1.0 Capsule Reviews
The amount of Amigraf 1.0 you take and how often you take it depends on the type of transplant you have, your body weight, and what other medicines you are taking. Follow your doctor’s instructions carefully. You should take it on an empty stomach, at least 1 hour before or 2 hours after a meal. Take this medicine regularly to get the maximum benefit and keep taking it, even if you feel well. If you stop taking it, you may increase the chances of rejecting your transplanted organ.
Amigraf 1.0 has many potential side effects. It can cause or worsen diabetes and kidney problems. These need urgent medical attention. Other common side effects include tremor, infections, high blood pressure, headache, and insomnia. If the side effects do not go away or get worse, tell your doctor. Amigraf 1.0 lowers your immune system making you susceptible to catching more infections than usual.
Before taking this medicine, tell your doctor if you have kidney, liver, or heart problems, diabetes, or high blood pressure. Also let your doctor know what other medications you are taking, especially for infections, pain, and arthritis. These and others may affect, or be affected by, this medicine. You should limit your exposure to the sun and UV (ultraviolet) light while taking it because immunosuppressants could increase your risk of skin cancer.
Both men and women using this medicine should use effective birth control to prevent pregnancy. This medicine is not normally recommended during pregnancy or while breastfeeding unless it is clearly needed. Before and during treatment you will need frequent medical tests to monitor your progress, and your blood pressure will need to be checked often.
How Amigraf 1.0 Capsule Works
How to Use Amigraf 1.0 Capsule
Benefits of Amigraf 1.0 Capsule
- In Prevention of organ rejection in transplant patients: Amigraf 1.0 belongs to a group of medicines known as immunosuppressants. Organ rejection happens when your immune system treats the new organ as an invader and attacks it. This medicine weakens your immune response (which usually fights infection) and reduces the chance of your body attacking the transplanted organ. It is used in combination with other medicines to make it much more likely that your transplant operation will be successful. You should continue taking the medicine and should not stop it until your doctor says so.
Uses of Amigraf 1.0 Capsule
- Prevention of organ rejection in transplant patients
Amigraf 1.0 Capsule Side Effects
Safety Tips
Quick Tips
- Your doctor may monitor your kidney function regularly. Drink 8 to 10 glasses of water per day to help with your kidney function.
- Your doctor may get regular blood tests done to check the levels of blood cells in your blood. Inform your doctor if you experience unexplained bruising or bleeding, sore throat, mouth ulcers, fever, or general illness.
- Amigraf 1.0 is used to prevent organ rejection in transplant patients.
- It may take 3 to 4 months for the medication to work. Keep taking it as prescribed.
- Do not stop taking Amigraf 1.0 without talking to your doctor first.
References
- Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1822.
- Tacrolimus. Princeton, New Jersey: Sandoz Inc; 2009.
- Tacrolimus [package Insert]. Karapakkam, Chennai: The Madras Pharmaceuticals; 2020.
- Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 972.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1305-309.
- Tacrolimus monohydrate. Camberley, Surrey: Sandoz Limited; 2010 [revised 27 Mar. 2017].
- Central Drugs Standard Control Organisation. Tacrolimus.